LAPAK89 Game Online x admin, Author at cancer research

About admin

This author has not yet filled in any details.
So far admin has created 4 blog entries.

LAPAK89 GAME ONLINE tampil sebagai Game Online yang dirancang untuk pengalaman bermain praktis dan aman. Platform ini menghadirkan akses cepat, antarmuka ringan, dan layanan customer service aktif 24 jam untuk mendukung setiap sesi permainan LAPAK89 Game Online x admin, Author at cancer research - ABBA Therapeutics Basel.

Sebagai situs resmi, LAPAK89 GAME ONLINE menghadirkan berbagai pilihan Main Game Online dengan performa server stabil, metode transaksi fleksibel, dan bonus yang relevan dengan kebutuhan pemain aktif. Setiap fitur disusun agar pemain dapat fokus mengejar peluang maxwin tanpa hambatan teknis.

Pengalaman bermain di lapak89 game online semakin nyaman dengan pola permainan transparan dan tips manajemen modal yang mudah diterapkan. Pemain yang ingin eksplorasi Main Game Online terkait LAPAK89 Game Online x admin, Author at cancer research - ABBA Therapeutics Basel bisa langsung memulai dari halaman resmi LAPAK89 GAME ONLINE dan menyesuaikan strategi sesuai gaya bermain masing-masing.

ABBA Therapeutics closed ”Seed B” financing round

By admin|2019-04-09T14:59:54+00:00August 20th, 2018|

ABBA Therapeutics closed ”Seed B” financing round Basel, Switzerland - 20.08.2018 - ABBA Therapeutics successfully closed “Seed B” financing round with European investors. The raised fund will be used to accelerate the preclinical efficacy study with cutting-edge animal models and advance two lead candidates for clinical efficacy study. About ABBA Therapeutics ABBA Therapeutics is a [...]

ABBA Therapeutics was selected for BaseLaunch program

By admin|2019-04-09T14:59:35+00:00September 18th, 2017|

ABBA Therapeutics was selected for BaseLaunch program Basel, Switzerland - 18.09.2017 - ABBA Therapeutics was selected to participate BaseLaunch program from more than 100 international applications. ABBA Therapeutics will receive non-dilutive funding CHF 10,000 for continuing its pipeline development. About ABBA Therapeutics ABBA Therapeutics is a Swiss biotechnology company founded in Basel in 2016. ABBA [...]

ABBA Therapeutics enters into OmniAb® Platform License Agreement With Ligand

By admin|2019-04-09T14:53:14+00:00März 28th, 2016|

ABBA Therapeutics enters into OmniAb® Platform License Agreement With Ligand Basel, Switzerland - 28.03.2016 - ABBA Therapeutics AG announces it has entered into a worldwide license agreement with Ligand Pharmaceuticals (NASDAQ: LGND). Under this agreement, ABBA Therapeutics will use OmniAb® platform, an industry-leading technology including OmniRat®, OmniMouse® and OmniFlic®, to generate fully human mono- and [...]